102 related articles for article (PubMed ID: 33009794)
1. [Alternative Variants of Pax4 Human Transcription Factor: Comparative Transcriptional Activity].
Melnikova AI; Krasnova TS; Zubkova NA; Tiulpakov AN; Rubtsov PM
Mol Biol (Mosk); 2020; 54(5):849-857. PubMed ID: 33009794
[TBL] [Abstract][Full Text] [Related]
2. Aberrant mRNA splicing of paired box 4 (PAX4) IVS7-1G>A mutation causing maturity-onset diabetes of the young, type 9.
Sujjitjoon J; Kooptiwut S; Chongjaroen N; Tangjittipokin W; Plengvidhya N; Yenchitsomanus PT
Acta Diabetol; 2016 Apr; 53(2):205-16. PubMed ID: 25951767
[TBL] [Abstract][Full Text] [Related]
3. PAX4 R192H and P321H polymorphisms in type 2 diabetes and their functional defects.
Sujjitjoon J; Kooptiwut S; Chongjaroen N; Semprasert N; Hanchang W; Chanprasert K; Tangjittipokin W; Yenchitsomanus PT; Plengvidhya N
J Hum Genet; 2016 Nov; 61(11):943-949. PubMed ID: 27334367
[TBL] [Abstract][Full Text] [Related]
4. Defective PAX4 R192H transcriptional repressor activities associated with maturity onset diabetes of the young and early onset-age of type 2 diabetes.
Kooptiwut S; Plengvidhya N; Chukijrungroat T; Sujjitjoon J; Semprasert N; Furuta H; Yenchitsomanus PT
J Diabetes Complications; 2012; 26(4):343-7. PubMed ID: 22521316
[TBL] [Abstract][Full Text] [Related]
5. A novel PAX4 mutation in a Japanese patient with maturity-onset diabetes of the young.
Jo W; Endo M; Ishizu K; Nakamura A; Tajima T
Tohoku J Exp Med; 2011 Feb; 223(2):113-8. PubMed ID: 21263211
[TBL] [Abstract][Full Text] [Related]
6. Paired-homeodomain transcription factor PAX4 acts as a transcriptional repressor in early pancreatic development.
Smith SB; Ee HC; Conners JR; German MS
Mol Cell Biol; 1999 Dec; 19(12):8272-80. PubMed ID: 10567552
[TBL] [Abstract][Full Text] [Related]
7. Autoregulation and maturity onset diabetes of the young transcription factors control the human PAX4 promoter.
Smith SB; Watada H; Scheel DW; Mrejen C; German MS
J Biol Chem; 2000 Nov; 275(47):36910-9. PubMed ID: 10967107
[TBL] [Abstract][Full Text] [Related]
8. Activin A-induced expression of PAX4 in AR42J-B13 cells involves the increase in transactivation of E47/E12.
Kanno R; Ogihara T; Igarashi Y; Tanaka Y; Smith SB; Kojima I; German MS; Kawamori R; Watada H
Biochim Biophys Acta; 2006; 1759(1-2):44-50. PubMed ID: 16546275
[TBL] [Abstract][Full Text] [Related]
9. Expression of dominant negative form of PAX4 in human insulinoma.
Miyamoto T; Kakizawa T; Ichikawa K; Nishio S; Kajikawa S; Hashizume K
Biochem Biophys Res Commun; 2001 Mar; 282(1):34-40. PubMed ID: 11263967
[TBL] [Abstract][Full Text] [Related]
10. PAX4 gene variations predispose to ketosis-prone diabetes.
Mauvais-Jarvis F; Smith SB; Le May C; Leal SM; Gautier JF; Molokhia M; Riveline JP; Rajan AS; Kevorkian JP; Zhang S; Vexiau P; German MS; Vaisse C
Hum Mol Genet; 2004 Dec; 13(24):3151-9. PubMed ID: 15509590
[TBL] [Abstract][Full Text] [Related]
11. C.487C>T mutation in PAX4 gene causes MODY9: A case report and literature review.
Zhang D; Chen C; Yang W; Piao Y; Ren L; Sang Y
Medicine (Baltimore); 2022 Dec; 101(51):e32461. PubMed ID: 36595822
[TBL] [Abstract][Full Text] [Related]
12. The diabetes-linked transcription factor Pax4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1.
Brun T; Hu He KH; Lupi R; Boehm B; Wojtusciszyn A; Sauter N; Donath M; Marchetti P; Maedler K; Gauthier BR
Hum Mol Genet; 2008 Feb; 17(4):478-89. PubMed ID: 17989064
[TBL] [Abstract][Full Text] [Related]
13. PAX4 mutations in Thais with maturity onset diabetes of the young.
Plengvidhya N; Kooptiwut S; Songtawee N; Doi A; Furuta H; Nishi M; Nanjo K; Tantibhedhyangkul W; Boonyasrisawat W; Yenchitsomanus PT; Doria A; Banchuin N
J Clin Endocrinol Metab; 2007 Jul; 92(7):2821-6. PubMed ID: 17426099
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Evidence for Pathogenicity Demonstrates That BLK, KLF11, and PAX4 Should Not Be Included in Diagnostic Testing for MODY.
Laver TW; Wakeling MN; Knox O; Colclough K; Wright CF; Ellard S; Hattersley AT; Weedon MN; Patel KA
Diabetes; 2022 May; 71(5):1128-1136. PubMed ID: 35108381
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of pax4 on the human insulin and islet amyloid polypeptide (IAPP) promoters.
Campbell SC; Cragg H; Elrick LJ; Macfarlane WM; Shennan KI; Docherty K
FEBS Lett; 1999 Dec; 463(1-2):53-7. PubMed ID: 10601637
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of PAX4 reduces glucagon expression in differentiating hESCs.
Gage BK; Baker RK; Kieffer TJ
Islets; 2014; 6(2):e29236. PubMed ID: 25483960
[TBL] [Abstract][Full Text] [Related]
17. PAX4 Gene Transfer Induces α-to-β Cell Phenotypic Conversion and Confers Therapeutic Benefits for Diabetes Treatment.
Zhang Y; Fava GE; Wang H; Mauvais-Jarvis F; Fonseca VA; Wu H
Mol Ther; 2016 Feb; 24(2):251-260. PubMed ID: 26435408
[TBL] [Abstract][Full Text] [Related]
18. Pax4 represses pancreatic glucagon gene expression.
Petersen HV; Jørgensen MC; Andersen FG; Jensen J; F-Nielsen T; Jørgensen R; Madsen OD; Serup P
Mol Cell Biol Res Commun; 2000 Apr; 3(4):249-54. PubMed ID: 10891400
[TBL] [Abstract][Full Text] [Related]
19. Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity.
Biason-Lauber A; Boehm B; Lang-Muritano M; Gauthier BR; Brun T; Wollheim CB; Schoenle EJ
Diabetologia; 2005 May; 48(5):900-5. PubMed ID: 15834548
[TBL] [Abstract][Full Text] [Related]
20. Aberrant DNA demethylation in promoter region and aberrant expression of mRNA of PAX4 gene in hematologic malignancies.
Li Y; Nagai H; Ohno T; Ohashi H; Murohara T; Saito H; Kinoshita T
Leuk Res; 2006 Dec; 30(12):1547-53. PubMed ID: 16701883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
